메뉴 건너뛰기




Volumn 54, Issue 9, 2013, Pages 1934-1941

Clinicopathologic implication of A20/TNFAIP3 deletion in diffuse large B-cell lymphoma: An analysis according to immunohistochemical subgroups and rituximab treatment

Author keywords

A20 TNFAIP3; Deletion; Diffuse large B cell lymphoma; Fluorescence in situ hybridization; Prognosis

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; INTERFERON REGULATORY FACTOR 4; PREDNISOLONE; RITUXIMAB; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INDUCED PROTEIN 3; UNCLASSIFIED DRUG; VINCRISTINE;

EID: 84882943387     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2012.762511     Document Type: Article
Times cited : (18)

References (42)
  • 3
    • 80052412647 scopus 로고    scopus 로고
    • WHO classification of malignant lymphomas in Korea: Report of the third nationwide study
    • Kim JM, Ko YH, Lee SS, et al. WHO classification of malignant lymphomas in Korea: Report of the third nationwide study. Korean J Pathol 2011;45:254-260.
    • (2011) Korean J Pathol , vol.45 , pp. 254-260
    • Kim, J.M.1    Ko, Y.H.2    Lee, S.S.3
  • 4
    • 0034598746 scopus 로고    scopus 로고
    • Distinct types of diff use large B-cell lymphoma identified by gene expression profiling
    • Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diff use large B-cell lymphoma identified by gene expression profiling. Nature 2000;403:503-511.
    • (2000) Nature , vol.403 , pp. 503-511
    • Alizadeh, A.A.1    Eisen, M.B.2    Davis, R.E.3
  • 5
    • 68549124173 scopus 로고    scopus 로고
    • A new immunostain algorithm classifies diff use large B-cell lymphoma into molecular subtypes with high accuracy
    • Choi WW,Weisenburger DD,Greiner TC, et al. A new immunostain algorithm classifies diff use large B-cell lymphoma into molecular subtypes with high accuracy. Clin Cancer Res 2009;15:5494-5502.
    • (2009) Clin Cancer Res , vol.15 , pp. 5494-5502
    • Choi, W.W.1    Weisenburger, D.D.2    Greiner, T.C.3
  • 6
    • 9144237554 scopus 로고    scopus 로고
    • Confirmation of the molecular classification of diff use large B-cell lymphoma by immunohistochemistry using a tissue microarray
    • Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diff use large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004;103:275-282.
    • (2004) Blood , vol.103 , pp. 275-282
    • Hans, C.P.1    Weisenburger, D.D.2    Greiner, T.C.3
  • 7
    • 79955944673 scopus 로고    scopus 로고
    • Gene-expression profiling and not immunophenotypic algorithms predicts prognosis in patients with diff use large B-cell lymphoma treated with immunochemotherapy
    • Gutierrez-Garcia G, Cardesa-Salzmann T, Climent F, et al. Gene-expression profiling and not immunophenotypic algorithms predicts prognosis in patients with diff use large B-cell lymphoma treated with immunochemotherapy. Blood 2011;117:4836-4843.
    • (2011) Blood , vol.117 , pp. 4836-4843
    • Gutierrez-Garcia, G.1    Cardesa-Salzmann, T.2    Climent, F.3
  • 8
    • 0037217921 scopus 로고    scopus 로고
    • Clinical impact of the diff erentiation profile assessed by immunophenotyping in patients with diff use large B-cell lymphoma
    • Colomo L, Lopez-Guillermo A,Perales M, et al. Clinical impact of the diff erentiation profile assessed by immunophenotyping in patients with diff use large B-cell lymphoma. Blood 2003;101:78-84.
    • (2003) Blood , vol.101 , pp. 78-84
    • Colomo, L.1    Lopez-Guillermo, A.2    Perales, M.3
  • 9
    • 79951802728 scopus 로고    scopus 로고
    • A 20 deficiency in B cells enhances B-cell proliferation and results in the development of autoantibodies
    • Hovelmeyer N, Reissig S, Xuan N T, et al. A 20 deficiency in B cells enhances B-cell proliferation and results in the development of autoantibodies. Eur J Immunol 2011;41:595-601.
    • (2011) Eur J Immunol , vol.41 , pp. 595-601
    • Hovelmeyer, N.1    Reissig, S.2    Xuan, N.T.3
  • 10
    • 79955956764 scopus 로고    scopus 로고
    • A20 (TNFAIP3) genetic alterations in EBV-associated AIDS-related lymphoma
    • Giulino L, Mathew S, Ballon G, et al. A20 (TNFAIP3) genetic alterations in EBV-associated AIDS-related lymphoma. Blood 2011;117:4852-4854.
    • (2011) Blood , vol.117 , pp. 4852-4854
    • Giulino, L.1    Mathew, S.2    Ballon, G.3
  • 11
    • 80051561179 scopus 로고    scopus 로고
    • A20 regulation of nuclear factor-kappaB: Perspectives for inflammatory lung disease
    • Kelly C, Shields MD, Elborn JS, et al. A20 regulation of nuclear factor-kappaB: Perspectives for inflammatory lung disease. Am J Respir Cell Mol Biol 2011;44:743-748.
    • (2011) Am J Respir Cell Mol Biol , vol.44 , pp. 743-748
    • Kelly, C.1    Shields, M.D.2    Elborn, J.S.3
  • 12
    • 80052195163 scopus 로고    scopus 로고
    • A20 (TNFAIP3) deficiency in myeloid cells triggers erosive polyarthritis resembling rheumatoid arthritis
    • Matmati M, Jacques P, Maelfait J, et al. A20 (TNFAIP3) deficiency in myeloid cells triggers erosive polyarthritis resembling rheumatoid arthritis. Nat Genet 2011;43:908-912.
    • (2011) Nat Genet , vol.43 , pp. 908-912
    • Matmati, M.1    Jacques, P.2    Maelfait, J.3
  • 13
    • 79952192654 scopus 로고    scopus 로고
    • Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus
    • Adrianto I, Wen F, Templeton A, et al. Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus. Nat Genet 2011;43:253-258.
    • (2011) Nat Genet , vol.43 , pp. 253-258
    • Adrianto, I.1    Wen, F.2    Templeton, A.3
  • 14
    • 77955504366 scopus 로고    scopus 로고
    • Tumor suppressor A20 protects against cardiac hypertrophy and fibrosis by blocking transforming growth factor-beta-activated kinase 1-dependent signaling
    • Huang H, Tang QZ, Wang AB, et al. Tumor suppressor A20 protects against cardiac hypertrophy and fibrosis by blocking transforming growth factor-beta-activated kinase 1-dependent signaling. Hypertension 2010;56:232-239.
    • (2010) Hypertension , vol.56 , pp. 232-239
    • Huang, H.1    Tang, Q.Z.2    Wang, A.B.3
  • 15
    • 79952762862 scopus 로고    scopus 로고
    • A20 modulates lipid metabolism and energy production to promote liver regeneration
    • Damrauer SM, Studer P, da Silva CG, et al. A20 modulates lipid metabolism and energy production to promote liver regeneration. PLoS One 2011;6: E17715.
    • (2011) PLoS One , vol.6
    • Damrauer, S.M.1    Studer, P.2    Da Silva, C.G.3
  • 16
    • 66049124247 scopus 로고    scopus 로고
    • TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma
    • Schmitz R, Hansmann ML, Bohle V, et al. TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma. J Exp Med 2009;206:981-989.
    • (2009) J Exp Med , vol.206 , pp. 981-989
    • Schmitz, R.1    Hansmann, M.L.2    Bohle, V.3
  • 18
    • 0036668002 scopus 로고    scopus 로고
    • Chromosomal imbalances in diff use large B-cell lymphoma detected by comparative genomic hybridization
    • Berglund M, Enblad G, Flordal E, et al. Chromosomal imbalances in diff use large B-cell lymphoma detected by comparative genomic hybridization. Mod Pathol 2002;15:807-816.
    • (2002) Mod Pathol , vol.15 , pp. 807-816
    • Berglund, M.1    Enblad, G.2    Flordal, E.3
  • 19
    • 4444365802 scopus 로고    scopus 로고
    • Clinicopathologic significance and prognostic value of chromosomal imbalances in diff use large B-cell lymphomas
    • Bea S, Colomo L, Lopez-Guillermo A, et al. Clinicopathologic significance and prognostic value of chromosomal imbalances in diff use large B-cell lymphomas. J Clin Oncol 2004;22:3498-3506.
    • (2004) J Clin Oncol , vol.22 , pp. 3498-3506
    • Bea, S.1    Colomo, L.2    Lopez-Guillermo, A.3
  • 20
    • 70350504882 scopus 로고    scopus 로고
    • TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas
    • Honma K, Tsuzuki S, Nakagawa M, et al. TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas. Blood 2009;114:2467-2475.
    • (2009) Blood , vol.114 , pp. 2467-2475
    • Honma, K.1    Tsuzuki, S.2    Nakagawa, M.3
  • 21
    • 66649112854 scopus 로고    scopus 로고
    • Frequent inactivation of A20 in B-cell lymphomas
    • Kato M, Sanada M, Kato I, et al. Frequent inactivation of A20 in B-cell lymphomas. Nature 2009;459:712-716.
    • (2009) Nature , vol.459 , pp. 712-716
    • Kato, M.1    Sanada, M.2    Kato, I.3
  • 22
    • 76749103364 scopus 로고    scopus 로고
    • A20 is targeted by promoter methylation, deletion and inactivating mutation in MALT lymphoma
    • Chanudet E, Huang Y, Ichimura K, et al. A20 is targeted by promoter methylation, deletion and inactivating mutation in MALT lymphoma. Leukemia 2010;24:483-487.
    • (2010) Leukemia , vol.24 , pp. 483-487
    • Chanudet, E.1    Huang, Y.2    Ichimura, K.3
  • 23
    • 80052431620 scopus 로고    scopus 로고
    • Tumor suppressor TNFAIP3 (A20) is frequently deleted in Sezary syndrome
    • Braun FC, Grabarczyk P, Mobs M, et al. Tumor suppressor TNFAIP3 (A20) is frequently deleted in Sezary syndrome. Leukemia 2011;25:1494-1501.
    • (2011) Leukemia , vol.25 , pp. 1494-1501
    • Braun, F.C.1    Grabarczyk, P.2    Mobs, M.3
  • 24
    • 79952730520 scopus 로고    scopus 로고
    • A20 ABIN-1/2, and CARD11 mutations and their prognostic value in gastrointestinal diff use large B-cell lymphoma
    • Dong G, Chanudet E, Zeng N, et al. A20, ABIN-1/2, and CARD11 mutations and their prognostic value in gastrointestinal diff use large B-cell lymphoma. Clin Cancer Res 2011;17:1440-1451.
    • (2011) Clin Cancer Res , vol.17 , pp. 1440-1451
    • Dong, G.1    Chanudet, E.2    Zeng, N.3
  • 25
    • 77951800247 scopus 로고    scopus 로고
    • Class III beta-tubulin shows unique expression patterns in a variety of neoplastic and non-neoplastic lymphoproliferative disorders
    • Yoon SO,Kim WY,GoH, et al. Class III beta-tubulin shows unique expression patterns in a variety of neoplastic and non-neoplastic lymphoproliferative disorders. Am J Surg Pathol 2010;34:645-655.
    • (2010) Am J Surg Pathol , vol.34 , pp. 645-655
    • Yoon, S.O.1    Kim, W.Y.2    Go, H.3
  • 26
    • 47749103376 scopus 로고    scopus 로고
    • MYC translocation and an increased copy number predict poor prognosis in adult diff use large B-cell lymphoma (DLBCL), especially in germinal centre-like B cell (GCB) type
    • Yoon SO, Jeon YK, Paik JH, et al. MYC translocation and an increased copy number predict poor prognosis in adult diff use large B-cell lymphoma (DLBCL), especially in germinal centre-like B cell (GCB) type. Histopathology 2008;53:205-217.
    • (2008) Histopathology , vol.53 , pp. 205-217
    • Yoon, S.O.1    Jeon, Y.K.2    Paik, J.H.3
  • 27
    • 70349639243 scopus 로고    scopus 로고
    • Increased quantity of tumorinfiltrating FOXP3-positive regulatory T cells is an independent predictor for improved clinical outcome in extranodal NK/T-cell lymphoma
    • Kim WY, Jeon YK, Kim TM, et al. Increased quantity of tumorinfiltrating FOXP3-positive regulatory T cells is an independent predictor for improved clinical outcome in extranodal NK/T-cell lymphoma. Ann Oncol 2009;20:1688-1696.
    • (2009) Ann Oncol , vol.20 , pp. 1688-1696
    • Kim, W.Y.1    Jeon, Y.K.2    Kim, T.M.3
  • 28
    • 80052892884 scopus 로고    scopus 로고
    • Th ymic extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue :A clinicopathological and genetic analysis of six cases
    • Go H, Cho HJ, Paik JH, et al. Th ymic extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue :A clinicopathological and genetic analysis of six cases. Leuk Lymphoma 2011;52:2276-2283.
    • (2011) Leuk Lymphoma , vol.52 , pp. 2276-2283
    • Go, H.1    Cho, H.J.2    Paik, J.H.3
  • 29
    • 0028919385 scopus 로고
    • Trisomy 3 in low-grade B-cell lymphomas of mucosa-associated lymphoid tissue
    • Wotherspoon AC, Finn TM, Isaacson PG. Trisomy 3 in low-grade B-cell lymphomas of mucosa-associated lymphoid tissue. Blood 1995;85:2000-2004.
    • (1995) Blood , vol.85 , pp. 2000-2004
    • Wotherspoon, A.C.1    Finn, T.M.2    Isaacson, P.G.3
  • 30
    • 84860347892 scopus 로고    scopus 로고
    • A novel A20 (TNFAIP3) antibody (Ber-A20) can be used to detect unmutated A20 by immunohistology
    • Hirsch B, Grunbaum M, Wagner F, et al. A novel A20 (TNFAIP3) antibody (Ber-A20) can be used to detect unmutated A20 by immunohistology. Histopathology 2012;60:E19-E27.
    • (2012) Histopathology , vol.60
    • Hirsch, B.1    Grunbaum, M.2    Wagner, F.3
  • 31
    • 34447507710 scopus 로고    scopus 로고
    • A20/TNFAIP3, a new estrogen-regulated gene that confers tamoxifen resistance in breast cancer cells
    • Vendrell JA, Ghayad S, Ben-Larbi S, et al. A20/TNFAIP3, a new estrogen-regulated gene that confers tamoxifen resistance in breast cancer cells. Oncogene 2007;26:4656-4667.
    • (2007) Oncogene , vol.26 , pp. 4656-4667
    • Vendrell, J.A.1    Ghayad, S.2    Ben-Larbi, S.3
  • 32
    • 77649100933 scopus 로고    scopus 로고
    • Targeting A20 decreases glioma stem cell survival and tumor growth
    • Hjelmeland AB, Wu Q, Wickman S, et al. Targeting A20 decreases glioma stem cell survival and tumor growth. PLoS Biol 2010;8: E1000319.
    • (2010) PLoS Biol , vol.8
    • Hjelmeland, A.B.1    Wu, Q.2    Wickman, S.3
  • 33
    • 0035067050 scopus 로고    scopus 로고
    • A 20 zinc finger protein inhibits TNF-induced apoptosis and stress response early in the signaling cascades and independently of binding to TRAF2 or 14-3-3 proteins
    • Lademann U, Kallunki T, Jäättelä M. A 20 zinc finger protein inhibits TNF-induced apoptosis and stress response early in the signaling cascades and independently of binding to TRAF2 or 14-3-3 proteins. Cell Death Differ 2001;8:265.
    • (2001) Cell Death Differ , vol.8 , pp. 265
    • Lademann, U.1    Kallunki, T.2    Jäättelä, M.3
  • 34
    • 84862819723 scopus 로고    scopus 로고
    • Targeting A20 enhances TRAILinduced apoptosis in hepatocellular carcinoma cells
    • Dong B, Lv G, Wang Q, et al. Targeting A20 enhances TRAILinduced apoptosis in hepatocellular carcinoma cells. Biochem Biophys Res Commun 2012;418:433-438.
    • (2012) Biochem Biophys Res Commun , vol.418 , pp. 433-438
    • Dong, B.1    Lv, G.2    Wang, Q.3
  • 35
    • 67650456585 scopus 로고    scopus 로고
    • A20 is overexpressed in glioma cells and may serve as a potential therapeutic target
    • Guo Q, Dong H, Liu X, et al. A20 is overexpressed in glioma cells and may serve as a potential therapeutic target. Expert Opin Ther Targets 2009;13:733-741.
    • (2009) Expert Opin Ther Targets , vol.13 , pp. 733-741
    • Guo, Q.1    Dong, H.2    Liu, X.3
  • 36
    • 84856213846 scopus 로고    scopus 로고
    • The diverse and complex roles of NF-kappaB subunits in cancer
    • Perkins ND. The diverse and complex roles of NF-kappaB subunits in cancer. Nat Rev Cancer 2012;12:121-132.
    • (2012) Nat Rev Cancer , vol.12 , pp. 121-132
    • Perkins, N.D.1
  • 37
    • 34250365875 scopus 로고    scopus 로고
    • Genome-wide arraybased comparative genomic hybridization of ocular marginal zone B cell lymphoma: Comparison with pulmonary and nodal marginal zone B cell lymphoma
    • Kim WS, Honma K, Karnan S, et al. Genome-wide arraybased comparative genomic hybridization of ocular marginal zone B cell lymphoma: Comparison with pulmonary and nodal marginal zone B cell lymphoma. Genes Chromosomes Cancer 2007;46:776-783.
    • (2007) Genes Chromosomes Cancer , vol.46 , pp. 776-783
    • Kim, W.S.1    Honma, K.2    Karnan, S.3
  • 38
    • 36549072913 scopus 로고    scopus 로고
    • TNFAIP3 is the target gene of chromosome band 6q23.3-q24.1 loss in ocular adnexal marginal zone B cell lymphoma
    • Honma K, Tsuzuki S, Nakagawa M, et al. TNFAIP3 is the target gene of chromosome band 6q23.3-q24.1 loss in ocular adnexal marginal zone B cell lymphoma. Genes Chromosomes Cancer 2008;47:1-7.
    • (2008) Genes Chromosomes Cancer , vol.47 , pp. 1-7
    • Honma, K.1    Tsuzuki, S.2    Nakagawa, M.3
  • 40
    • 12144289671 scopus 로고    scopus 로고
    • Building an outcome predictor model for diff use large B-cell lymphoma
    • Saez AI, Saez AJ, Artiga MJ, et al. Building an outcome predictor model for diff use large B-cell lymphoma. Am J Pathol 2004;164:613-622.
    • (2004) Am J Pathol , vol.164 , pp. 613-622
    • Saez, A.I.1    Saez, A.J.2    Artiga, M.J.3
  • 41
    • 1842529746 scopus 로고    scopus 로고
    • Immunohistochemical expression patterns of germinal center and activation B-cell markers correlate with prognosis in diff use large B-cell lymphoma
    • Chang CC, McClintock S,Clevel and R P, et al. Immunohistochemical expression patterns of germinal center and activation B-cell markers correlate with prognosis in diff use large B-cell lymphoma. Am J Surg Pathol 2004;28:464-470.
    • (2004) Am J Surg Pathol , vol.28 , pp. 464-470
    • Chang, C.C.1    Sclevel, M.2
  • 42
    • 79960411409 scopus 로고    scopus 로고
    • Prognostic impact of MUM1 expression by immunohistochemistry on primary mediastinal large B-cell lymphoma
    • De Mello CA, De Andrade VP, De Lima VC, et al. Prognostic impact of MUM1 expression by immunohistochemistry on primary mediastinal large B-cell lymphoma. Leuk Lymphoma 2011;52:1495-1503.
    • (2011) Leuk Lymphoma , vol.52 , pp. 1495-1503
    • De Mello, C.A.1    De Andrade, V.P.2    De Lima, V.C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.